Diaverum expands provision of life-enhancing renal care in Brazil

Report this content

Diaverum, the Swedish-born, global renal care provider, is pleased to announce that it is expanding its presence in Brazil with two new clinics. Its de novo reference clinic in Sergipe, standing proud as one of the largest dialysis centres in the country, along with its acquired clinic in São Paulo, offering comprehensive multidisciplinary care, will enable it to significantly increase access to life-enhancing renal care across the country.

Since entering Brazil in 2017, Diaverum has been ambitiously expanding its presence across the country. The newly acquired clinic in São Paulo will further strengthen Diaverum’s established presence in Brazil’s largest city. Meanwhile, the all-new Sergipe clinic represents a significant milestone in improving the quality of life for chronic kidney disease (CKD) patients in Brazil's smallest state, where Diaverum already operates two clinics. These new openings come less than a year after the launch of a new private clinic in Guarulhos, the second most populous city in the state of São Paulo.

A new era for CKD patients in Sergipe

Located in the city of Aracaju, the capital of Sergipe, Diaverum’s new clinic spans a total area of 2,700m² and boasts a modern structure equipped with cutting-edge technology. It provides a comfortable and safe environment for patients, featuring 100 dialysis stations, offering the capacity to treat over 600 haemodialysis patients. In addition, the clinic hosts one of Brazil's largest peritoneal dialysis programmes, serving over 200 patients. The Aracaju clinic receives patients from many surrounding cities.

Expanding Diaverum’s presence in São Paulo

The newly acquired clinic, featuring 46 fully equipped dialysis stations, will deliver haemodialysis treatment to approximately 270 patients. Additionally, the facility is poised for further expansion, increasing Diaverum’s capacity to treat over 66% of patients receiving treatment across the region. The clinic’s primary focus will be on providing high-quality haemodialysis to public patients, while also offering comprehensive multidisciplinary care through specialised consultations, nutritional support, and social services.

Rafael Romanini, Diaverum’s SVP Europe & LatAm regions, commented on the news: “These are exciting times for Brazil and represent a significant milestone in our growth plan in the country. We are committed to enhancing the lives of people with kidney disease by offering world-class care supported by our innovative, digital solutions. Additionally, we are dedicated to broadening access to the highest quality of care by opening clinics in areas with high need”.

Luciano Bonaldo, Country Managing Director for Diaverum Brazil, shared the following: “This highly-strategic move marks a critical step in our mission to deliver high-quality renal care to even more patients. It will significantly increase our capacity in both regions and enable us to continue providing life-enhancing renal care to a growing number of patients”.

Paulo Cicogna, Medical Director for Diaverum Brazil, highlighted the impact on patients: “By expanding our capacity and introducing a multidisciplinary approach, we are not only addressing the growing demand for haemodialysis but also enhancing the overall patient experience. Our commitment remains on providing comprehensive, patient-centred care, ensuring that every individual receives the best possible treatment and support”.

With this news, Diaverum now operates 11 treatment centres across Brazil, as well as one vascular access centre. More than 1,350 staff will be caring for over 4,400 patients on an annual basis.

Marianna Sofocleous
Global Communications & Editorial Director
marianna.sofocleous@diaverum.com 

About Diaverum

Diaverum is a Swedish-born, multinational healthcare organisation that provides life-enhancing renal care to patients with chronic kidney disease, empowering them to live fulfilling lives.

Our vision is to transform renal care, delivering and broadening access to the highest quality of kidney care for patients around the world. At the heart of what we do is our standardised care delivery model, continuously evolving digital & AI infrastructure and people caring for patients with competence, passion and inspiration.

As a global leader and the largest independent renal service provider in Europe, we have 13,000 healthcare professionals caring for around 41,000 patients across 450 clinics in 24 countries globally. We provide renal care personalised to patients’ needs and choices, offering a portfolio of treatments ranging from preventive care, haemodialysis, peritoneal dialysis and home care, to the coordination of patients’ comorbidities and holiday dialysis.

Founded in 1991 in Malmö, Sweden, Diaverum is part of the M42 group of companies, a first-of-its-kind integrated health powerhouse committed to the sustainable future of health.

www.diaverum.com 

Tags:

Subscribe

Media

Media

Quotes

These are exciting times for Brazil and represent a significant milestone in our growth plan in the country. We are committed to enhancing the lives of people with kidney disease by offering world-class care supported by our innovative, digital solutions. Additionally, we are dedicated to broadening access to the highest quality of care by opening clinics in areas with high need.
Rafael Romanini, Diaverum’s SVP Europe & LatAm regions
This highly-strategic move marks a critical step in our mission to deliver high-quality renal care to even more patients. It will significantly increase our capacity in both regions and enable us to continue providing life-enhancing renal care to a growing number of patients.
Luciano Bonaldo, Country Managing Director for Diaverum Brazil
By expanding our capacity and introducing a multidisciplinary approach, we are not only addressing the growing demand for haemodialysis but also enhancing the overall patient experience. Our commitment remains on providing comprehensive, patient-centred care, ensuring that every individual receives the best possible treatment and support.
Paulo Cicogna, Medical Director for Diaverum Brazil